The Natural History and Epidemiology of Diabetic Nephropathy: Implications for Prevention and Control

JAMA: The Journal of the American Medical Association

Volumn 263, Issue 14, 1990, Pages 1954-1960

  Selby, Joseph V ^a,b   Fitz Simmons, Stacey C ^c   Newman, Jeffrey M ^d   Katz, Patricia P ^b   Sepe, Stephen ^d   Showstack, Jonathan ^b  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC NEPHROPATHY; HUMAN; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC NEPHROPATHIES; DIETARY PROTEINS; ETHNIC GROUPS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; RISK FACTORS; SEX FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025249259     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1990.03440140080036     Document Type: Review

References (106)

1. Friedman EA. Diabetic renal disease. In: Ellenberg M, Rifkin H, eds. Diabetes Mellitus: Theory and Practice. New York, NY: Medical Examination Publishing Co Inc; 1983:759-776.
2. Sugimoto T, Rosansky SJ. The incidence of treated end-stage renal disease in the eastern United States: 1973-1979. Am J Public Health. 1984; 74:14-17.
3. US Renal Data System. 1989 Annual Data Report. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 1989.
4. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic nephropathy: with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(suppl 2):64-78.
5. Mogensen CE. Renal function changes in diabetes. Diabetes. 1976;25(suppl 2):872-879.
6. Osterby R, Gundersen HJG. Glomerular size and structure in diabetes mellitus, I: early abnormalities. Diabetologia. 1975;11:225-229.
7. Hirose K, Tsuchida H, Osterby R, Gundersen JHG. A strong correlation between glomerular filtration rate and filtration surface in diabetic kidney hyperfunction. Lab Invest. 1980;43:434-437.
8. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982;72:375-380.
9. Anderson S, Brenner BM. Influence of antihypertensive therapy on development and progression of diabetic glomerulopathy. Diabetes Care. 1988;11:846-849.
10. Parving H-H, Noer I, Deckert T, et al. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia. 1976;12:161-166.
11. Osterby R. Early phases in the development of diabetic glomerulopathy: a quantitative electron microscopic study. Acta Med Scand Suppl. 1974; (574):1-82.
12. Steffes MW, Ellis EN, Mauer SM. Complications of diabetes mellitus and factors affecting their progression. Clin Chem. 1986;32(suppl B):B54-B61.
13. Mauer SM, Steffes MW, Goetz FC, Sutherland DER, Brown DM. Diabetic nephropathy: a perspective. Diabetes. 1983;32(suppl 2):52-55.
14. Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes. 1989;38:1077-1081.
15. Ellis D, Becker DJ, Dameron D, Lobes L, Drash AL. Proteinuria in children with insulindependent diabetes: relationship to duration of disease, metabolic control, and retinal changes. J Pediatr. 1983;102:673-680.
16. Mathiesen ER, Saurbrey N, Hommel E, Parving H-H. Prevalence of microalbuminuria in children with insulin-dependent diabetes. Acta Endocrinol Suppl (Copenh). 1986;275:14.
17. Niazy S, Feldt-Rasmussen B, Deckert T. Microalbuminuria in insulin-dependent diabetes: prevalence and practical consequences. J Diabetic Complications. 1987;1:76-80.
18. Damsgaard EM, Mogensen CE. Microalbuminuria in elderly hyperglycemic patients and controls. Diabetic Med. 1986;3:430-435.
19. Uusitupa M, Siitonen O, Penttila I, Antti A, Pyorala K. Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care. 1987;10:191-194.
20. Parving H-H, Oxenboll B, Svendsen PA, Christensen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh). 1982;100:550-555.
21. Viberti GC, Hill RD, Jarrett RJ, Argyropoulous A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1:1430-1432.
22. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PAA, Deckert T. Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia. 1984;26:406-410.
23. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.
24. Bennett PH. ‘Microalbuminuria’ and diabetes: a critique—assessment of urinary albumin excretion and its role in screening for diabetic nephropathy. Am J Kidney Dis. 1989;13:29-34.
25. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med. 1989;320:966-970.
26. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturityonset diabetes. N Engl J Med. 1984;310:356-360.
27. Jarrett RJ, Viberti BC, Argyropoulous A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med. 1984;1:17-19.
28. Andersen AR, Christiansen JK, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25:496-501.
29. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985;78:785-794.
30. Parving H-H, Andersen AR, Smidt UM, Christensen JS, Oxenboll B, Svendsen PAA. Diabetic nephropathy and arterial hypertension: the effect of antihypertensive treatment. Diabetes. 1983;32(suppl 2):83-87.
31. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one, II: factors influencing the prognosis. Diabetologia. 1978;14:371-377.
32. Hasslacher C, Stech W, Wahl P, Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type I (insulin-dependent) diabetes. Diabetologia. 1985;28:6-11.
33. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia. 1985;28:590-596.
34. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty one, I: survival, causes of death, and complications. Diabetologia. 1978;14:363-370.
35. Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int. 1982;21:730-738.
36. Ballard DJ, Humphrey LL, Melton LJ III, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. Diabetes. 1988;37:405-412.
37. Klein R, Klein BEK, Moss S, DeMets DL. Proteinuria in diabetes. Arch Intern Med. 1988; 148:181-186.
38. Kamenetzky SA, Bennett PH, Dippe SE, Miller M, LeCompte PM. A clinical and histological study of diabetic nephropathy in the Pima Indians. Diabetes. 1974;23:61-68.
39. Rate RG, Knowler WC, Morse HG, et al. Diabetes mellitus in Hopi and Navajo Indians: prevalence of microvascular complications. Diabetes. 1983;32:894-899.
40. Schmitz A, Gundersen HJG, Mogensen CE, et al. Diabetic glomerulopathy in type II patients—is it different from type I? Acta Endocrinol Suppl (Copenh). 1986;275:13.
41. Humphrey LL, Ballard DJ, Frohnert PP, Chu C-P, O’Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus: a population-based study in Rochester, Minnesota. Ann Intern Med. 1989;111:788-796.
42. Kofoed-Enevoldson A, Borch-Johnson K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes. 1987;36:205-209.
43. Christensen JS, Gammelgaard J, Tronier B, Svenden PA, Parving H-H. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int. 1982;21:683-688.
44. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment: the mesangial regions. Diabetologia. 1979;17:243-248.
45. Mauer SM, Sutherland DER, Steffes MW, et al. Pancreatic islet transplantation: effect on the glomerular lesions of experimental diabetes in the rat. Diabetes. 1974;23:748-753.
46. Bilous RW, Mauer SM, Sutherland DER, Najarian JS, Goetz FC, Steffes MW. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulindependent diabetes. N Engl J Med. 1989;321:80-85.
47. The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med. 1984;311:365-372.
48. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet. 1986;2:1300-1304.
49. Holman RR, Dornan TL, Mayon-White V, et al. Prevention of deterioration of renal and sensorynerve function by more intensive management of insulin-dependent diabetic patients. Lancet. 1983;1:204-208.
50. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo Study. Br Med J. 1986;293:1195-1199.
51. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes. 1986;35:530-545.
52. The DCCT Research Group. Are continuing studies of metabolic control of microvascular complications in insulin-dependent diabetes mellitus justified? N Engl J Med. 1988;318:246-250.
53. Tamborlane WV, Puklin JE, Bergman M, et al. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care. 1982;5:58-64.
54. Miller DG, Hampton L, Fredricka V, et al. The use of an open-loop pump in type I diabetics with renal insufficiency. Diabetic Nephropathy. 1984; 3:19-21.
55. Simonson DC. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care. 1988;11:821-827.
56. Christlieb AR, Warram JH, Krolewski AS, et al. Hypertension: the major risk factor in juvenileonset insulin-dependent diabetics. Diabetes. 1981; 30(suppl 2):90-96.
57. Jensen T, Borch-Johnsen K, Deckert T. Changes in blood pressure and renal function in patients with type I (insulin-dependent) diabetes mellitus prior to clinical diabetes nephropathy. Diabetes Res. 1987;4:159-162.
58. Mauer SM, Steffes MW, Azar S, Kupcho-Sandberg S, Brown DM. The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes. 1978;27:738-744.
59. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacologic amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-1930.
60. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T. Relationship between blood pressure and urinary albumin excretion in development of micoralbuminuria. Diabetes. 1990;39:345-349.
61. Viberti GC, Keen H. Wiseman MJ. Raised arterial pressure in parents of proteinuric insulindependent diabetics. Br Med J. 1987;295:515-517.
62. Krolewski AS, Canessa M, Warram JH, et al. Predispostion to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-145.
63. Krolewski AS. The natural history of diabetic nephropathy in type I diabetes and the role of hypertension. Ann Intern Med. 1989;110:795-798.
64. Knowler WC, Bennett PH, Nelson RG. Prediabetic blood pressure predicts albuminuria after development of NIDDM. Diabetes. 1988;37(suppl 1):120a. Abstract.
65. Wiseman M, Viberti GC, Mackintosh D, Jarrett RF, Keen H. Glycemia, arterial pressure and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984;26:401-405.
66. Keen H, Chlouverakis C, Fuller JH, Jarrett RJ. The concomitants of raised blood sugar: studies in newly detected hyperglycemics, II: urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guy’s Hosp Rep. 1969;118:247-252.
67. Viberti GC, Bending JJ. Early diabetic nephropathy. Adv Nephrol. 1988;17:101-112.
68. Mimran A, Insua A, Ribstein J, Bringer J, Monnier L. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care. 1988;11:850-853.
69. Parving H-H, Smidt UM, Andersen AR, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983;1:1175-1178.
70. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin-converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J. 1986;293:471-474.
71. Taguma AC, Kitamoto UY, Futaki G, et al. Effect of captopril on heavy proteinuria in azotemic diabetes. N Engl J Med. 1985;313:1617-1620.
72. The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus. Arch Intern Med. 1987;147:830-842.
73. The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus. Arch Intern Med. 1987;147:1165-1166.
74. Rosenstock J, Raskin P. Early diabetic nephropathy: assessment and potential therapeutic interventions. Diabetes Care. 1986;9:529-545.
75. Hawthorne V, Herman WH, eds. International Symposium on Preventing the Kidney Disease of Diabetes Mellitus: public health perspectives. Am J Kidney Dis. 1989;13:2-6.
76. Kaplan NM, Rosenstock J, Raskin P. A differing view of treatment of hypertension in patients with diabetes mellitus. Arch Intern Med. 1987;147: 1160-1162.
77. Keane WF, Anderson S, Aurell M, de Zeeuw D, Narins RG, Povar G. Angiotension-converting enzyme inhibitors and progressive renal insufficiency. Ann Intern Med. 1989;111:503-516.
78. Feig PU, Rutan GH. Angiotension-converting enzyme inhibitors: the end of end-stage renal disease? Ann Intern Med. 1989;111:451-452.
79. Hostetter TH, Meyer TW, Rennke HG, Brenner BM. Chronic effects of dietary protein on renal structure and function in the rat with intact and reduced renal mass. Kidney Int. 1986;30:509-517.
80. Don BR, Schambelan M. Diabetes, dietary protein and glomerular hyperfiltration. West J Med. 1987;147:449-455.
81. Wiseman MJ, Bogneth E, Dodds R, Keen H, Viberti GC. Changes in renal function in response to protein restricted diet in type I diabetes. Diabetologia. 1987;30:154-159.
82. Cohen DL, Dodds R, Viberti GC. Reduction of microalbuminuria and glomerular filtration rate by dietary protein restriction in type I (insulin-dependent) diabetic patients: an effect independent of blood glucose control and arterial pressure changes. Diabetologia. 1986;29:528a. Abstract.
83. Evanoff GV, Thompson CS, Brown J, Weinman EJ. The effect of dietary protein restriction on the progression of diabetic nephropathy: a 12-month follow-up. Arch Intern Med. 1987;147:492-495.
84. Bending JJ, Dodds RA, Keen H, Viberti GC. Renal responses to restricted protein intake in diabetic nephropathy. Diabetes. 1988;37:1641-1646.
85. American Diabetes Association. Nutritional recommendations and principles for individuals with diabetes mellitus: 1986. Diabetes Care. 1987; 10:126-132.
86. Keane WF, Kasiske BL, O’Donnell MP. Hyperlipidemia and the progression of renal disease. Am J Clin Nutr. 1988;47:157-160.
87. Pettitt DJ, Saad MF. Inheritance of predisposition to renal insufficiency in diabetic men. Diabetes. 1988;37(suppl 1):51A. Abstract.
88. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. N Engl J Med. 1989;320:1161-1165.
89. Barnett AH, Pyke DA. The genetics of diabetic complications. Clin Endocrinol Metab. 1986;15: 715-726.
90. Rettig BS, Teutsch SM. The incidence of endstage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy. 1984;3:26-27.
91. Kappel DF, Van Tuinen M. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1975-84. Am J Kidney Dis. 1986;8:234-238.
92. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074-1079.
93. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC. Effect of proteinuria on mortality in NIDDM. Diabetes. 1988;37:1499-1504.
94. Nelson RG, Newman JM, Knowler WC, et al. Incidence of end-stage renal disease in type 2 diabetes mellitus in Pima Indians. Diabetologia. 1988; 31:730-736.
95. Pugh JA, Stern MP, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican-Americans. Am J Epidemiol. 1988;127: 135-144.
96. Newman JM, Marfin AA, Eggers PW, Helgerson SD. End-stage renal disease among Native Americans. Am J Public Health. 1990;80:318-319.
97. Haffner SM, Mitchell BD, Pugh JA, et al. Proteinuria in Mexican-Americans and non-Hispanic whites with NIDDM. Diabetes Care. 1989;12:530-536.
98. Eggers PW, Connerton R, McMullan M. The Medicare experience with end-stage renal disease. Health Care Financ Rev. 1984;5:69-88.
99. Raskin P, Rosenstock J. Aldose-reductase inhibitors and diabetic complications. Am J Med. 1987;83:298-306.
100. Nath KA. Platelets, antiplatelet therapy, and diabetic nephropathy. Mayo Clin Proc. 1988;63:80-85.
101. Watts GF, Hodgson B, Morris RW, Shaw KM, Polak A. Side-room tests to screen for microalbuminuria in diabetes mellitus. Diabetes Med. 1988;5:298-303.
102. Linton AS, Rowe DJF. Ames’ ‘Microbumintest’ evaluated, and its correlation with total protein and albumin concentration in urine. Clin Chem. 1988;34:1927-1928.
103. Coonrod BA, Ellis D, Becker DJ, et al. Assessment of Albusure and its usefulness in identifying IDDM subjects at increased risk for developing clinical diabetic nephropathy. Diabetes Care. 1989; 12:389-393.
104. Drury TF, Montgomery LE, Cohen BB. Health insurance and health care coverage of adult diabetics. In: Harris MI, Hamman RF, eds. Diabetes in America. Bethesda, Md: US Dept of Health and Human Services; 1985:XXXI-1-XXXI-14. Publication NIH 85-1468.
105. Poor’s access to care has declined markedly, new Robert Wood Johnson study reveals. Am Hosp Assoc News. May 1987.
106. Pugh JA. End-stage renal disease in Mexican-Americans. Presented at the Annual Meeting, American Public Health Association; November 15,1988; Boston, Mass.